Artwork

Contenido proporcionado por Ari Massoudi. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Ari Massoudi o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !

How Scientists Discover New Drugs

21:02
 
Compartir
 

Manage episode 448313938 series 3273121
Contenido proporcionado por Ari Massoudi. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Ari Massoudi o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

ITW Dr. Ivan De Weber, PhD - Cofounder-CEO at Cortex Discovery

👉https://www.linkedin.com/events/itwdrivandeweber-cofounder-ceoa7258560211001511937/theater/


Exciting news! 🚀 Join us for the next episode of our LinkedIn Live podcast featuring Dr. Ivan De Weber, PhD Weber, co-founder and CEO of Cortex Discovery, a groundbreaking startup revolutionizing drug discovery through AI!


🔬 From Academia to AI-Powered Drug Discovery

Dr. de Weber's journey is nothing short of inspiring. We'll explore his transition from cellular biology and pharmaceutical bioinformatics to founding a company at the cutting edge of AI-driven drug discovery. Learn how his lifelong quest for longevity research led to the creation of Cortex Discovery.


🧠 Unveiling Cortex Discovery's Innovative Approach

Discover how Cortex Discovery is disrupting preclinical drug discovery across all therapeutic areas with their proprietary AI models. We'll delve into:

• Their foundation model for drug property predictions

• The vast database of 750 million data points powering their deep learning system

• Recent breakthroughs, including the first AI-discovered compound proven to extend lifespan in a whole organism


💼 Business Insights and Future Outlook

Get an insider's perspective on:

• Cortex Discovery's unique business model and collaboration opportunities

• Challenges faced in the AI-driven drug discovery landscape

• The company's vision for the future of longevity research and pharmaceutical development

This episode is a must-watch for:

• Biotech and pharmaceutical executives

• Investors in the life sciences sector

• Academic researchers in pharmaceutical chemistry, longevity biology, and clinical medicine

• Anyone interested in the intersection of AI and drug discovery

Don't miss this opportunity to gain valuable insights into the future of AI-powered drug discovery and longevity research. Tune in to our LinkedIn Live podcast and be part of the conversation shaping the future of medicine!


👉https://www.linkedin.com/events/itwdrivandeweber-cofounder-ceoa7258560211001511937/theater/



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

104 episodios

Artwork
iconCompartir
 
Manage episode 448313938 series 3273121
Contenido proporcionado por Ari Massoudi. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Ari Massoudi o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

ITW Dr. Ivan De Weber, PhD - Cofounder-CEO at Cortex Discovery

👉https://www.linkedin.com/events/itwdrivandeweber-cofounder-ceoa7258560211001511937/theater/


Exciting news! 🚀 Join us for the next episode of our LinkedIn Live podcast featuring Dr. Ivan De Weber, PhD Weber, co-founder and CEO of Cortex Discovery, a groundbreaking startup revolutionizing drug discovery through AI!


🔬 From Academia to AI-Powered Drug Discovery

Dr. de Weber's journey is nothing short of inspiring. We'll explore his transition from cellular biology and pharmaceutical bioinformatics to founding a company at the cutting edge of AI-driven drug discovery. Learn how his lifelong quest for longevity research led to the creation of Cortex Discovery.


🧠 Unveiling Cortex Discovery's Innovative Approach

Discover how Cortex Discovery is disrupting preclinical drug discovery across all therapeutic areas with their proprietary AI models. We'll delve into:

• Their foundation model for drug property predictions

• The vast database of 750 million data points powering their deep learning system

• Recent breakthroughs, including the first AI-discovered compound proven to extend lifespan in a whole organism


💼 Business Insights and Future Outlook

Get an insider's perspective on:

• Cortex Discovery's unique business model and collaboration opportunities

• Challenges faced in the AI-driven drug discovery landscape

• The company's vision for the future of longevity research and pharmaceutical development

This episode is a must-watch for:

• Biotech and pharmaceutical executives

• Investors in the life sciences sector

• Academic researchers in pharmaceutical chemistry, longevity biology, and clinical medicine

• Anyone interested in the intersection of AI and drug discovery

Don't miss this opportunity to gain valuable insights into the future of AI-powered drug discovery and longevity research. Tune in to our LinkedIn Live podcast and be part of the conversation shaping the future of medicine!


👉https://www.linkedin.com/events/itwdrivandeweber-cofounder-ceoa7258560211001511937/theater/



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

104 episodios

Todos los episodios

×
 
Loading …

Bienvenido a Player FM!

Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.

 

Guia de referencia rapida